JP2006520343A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520343A5
JP2006520343A5 JP2006504553A JP2006504553A JP2006520343A5 JP 2006520343 A5 JP2006520343 A5 JP 2006520343A5 JP 2006504553 A JP2006504553 A JP 2006504553A JP 2006504553 A JP2006504553 A JP 2006504553A JP 2006520343 A5 JP2006520343 A5 JP 2006520343A5
Authority
JP
Japan
Prior art keywords
methoxypyridin
sulfonylamino
propyl
butyl
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006504553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520343A (ja
Filing date
Publication date
Priority claimed from DE10312073A external-priority patent/DE10312073A1/de
Application filed filed Critical
Publication of JP2006520343A publication Critical patent/JP2006520343A/ja
Publication of JP2006520343A5 publication Critical patent/JP2006520343A5/ja
Abandoned legal-status Critical Current

Links

JP2006504553A 2003-03-18 2004-03-05 2−(ブチル−1−スルホニルアミノ)−n−[1(r)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド、医薬としてのその使用及び該化合物を含有する医薬製剤 Abandoned JP2006520343A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10312073A DE10312073A1 (de) 2003-03-18 2003-03-18 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen
PCT/EP2004/002247 WO2004083157A1 (de) 2003-03-18 2004-03-05 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen

Publications (2)

Publication Number Publication Date
JP2006520343A JP2006520343A (ja) 2006-09-07
JP2006520343A5 true JP2006520343A5 (https=) 2007-04-19

Family

ID=32920928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006504553A Abandoned JP2006520343A (ja) 2003-03-18 2004-03-05 2−(ブチル−1−スルホニルアミノ)−n−[1(r)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド、医薬としてのその使用及び該化合物を含有する医薬製剤

Country Status (21)

Country Link
EP (1) EP1606237A1 (https=)
JP (1) JP2006520343A (https=)
KR (1) KR20050110681A (https=)
CN (1) CN100361943C (https=)
AR (1) AR043622A1 (https=)
AU (1) AU2004222137A1 (https=)
BR (1) BRPI0408441A (https=)
CA (1) CA2519022A1 (https=)
DE (1) DE10312073A1 (https=)
HR (1) HRP20050815A2 (https=)
MA (1) MA27749A1 (https=)
MX (1) MXPA05009763A (https=)
MY (1) MY176510A (https=)
NO (1) NO20054472L (https=)
NZ (1) NZ542476A (https=)
PE (1) PE20050307A1 (https=)
RS (1) RS20050690A (https=)
RU (1) RU2333202C2 (https=)
TW (1) TW200500342A (https=)
WO (1) WO2004083157A1 (https=)
ZA (1) ZA200506328B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009931A1 (de) * 2004-02-26 2005-09-15 Aventis Pharma Deutschland Gmbh Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
WO2007015775A2 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
EP2435407B1 (en) * 2009-05-29 2019-12-25 RaQualia Pharma Inc. Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472053B1 (en) * 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Similar Documents

Publication Publication Date Title
JP2021063088A5 (https=)
JP2023098946A5 (https=)
JP2004512328A5 (https=)
JP2019059760A5 (https=)
JP2009280627A5 (https=)
JP2008526757A5 (https=)
JP2008513510A5 (https=)
JP2013500977A5 (https=)
JP2010533131A5 (https=)
JP2009544665A5 (https=)
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
JP2004506682A5 (https=)
JP2008510758A5 (https=)
JP2002528502A5 (https=)
JP2005513014A5 (https=)
JP2024537043A5 (https=)
JP2005508963A5 (https=)
RU2008110644A (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
JP2006520343A5 (https=)
JP2004538314A5 (https=)
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
RU99121654A (ru) Средства для предотвращения или лечения болезней, связанных с чрезмерной пролиферацией эпителиальных пигментных клеток сетчатки
JP2002537232A5 (https=)
JP2008508350A5 (https=)
JP2011520877A5 (https=)